Summary
Cancer is known to be a genetic disease that is both polygenic and heterogeneous, in most cases involving changes in several genes in a stepwise fashion. The spectrum of individual genes involved in the initiation and progression of cancer is greatly influenced by genetic factors unique to each patient. A study of complex diseases such as cancer is complicated by the genetic heterogeneous background and environmental factors in the human population. Endometrial cancer (EC) is ranked fourth among invasive tumors in women. In Sweden, approximately 1300 women (27/100,000 women) are diagnosed annually. To be able to study the genetic alterations in cancer, the use of an animal model is very convenient. Females of the BDII strain are genetically predisposed to EC and 90% of female BDII rats develop EC during their lifetime. Thus, BDII rats have been used to model human EC with respect to the genetics of susceptibility and of tumor development. A set of rat EC tumors was analyzed using conventional cytogenetics and comparative genome hybridization (CGH). Chromosomal aberrations, i.e., gains, were found on rat chromosome 4 (RNO4). Using FISH analysis, we concluded that the Met oncogene and Cdk6 (cyclin-dependent kinase 6) were amplified in this set of EC tumors. The data from this investigation were used to analyze a set of human endometrial tumors for amplification of Cdk6 and Met. Our preliminary data are indicative for a good correlation between our findings in the BDII rat model for EAC and the situation in human EC. These data provide strong support for the use of animal model systems for better understanding and scrutinizing of human complex disease of cancer.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Sjöling Å, Walentinsson A, Helou K, et al. (2000) A genome wide study of genetic alterations in DMBA induced rat sarcomas. Rat Genome 6:75.
Laes J-F, Quan X, Ravoet M, et al. (2001) Analysis of candidate genes included in the mammary cancer susceptibility 1 (Mcs1) region. Mamm Genome 12:199–206.
Helou K, Walentinsson A, Beckmann B, et al. (2001) Analysis of genetic changes in rat endometrial carcinomas by means of comparative genome hybridization. Cancer Genet Cytogenet 127:118–127.
Cavanagh D, Fiorica JV, Hoffman MS, et al. (1999) Adenocarcinoma of the endometrium: an institutional review. Cancer Control; JMCC 6:354–360.
Hamta A, Adamovic T, Helou K, et al. (2005) Cytogenetic aberrations in spontaneous endometrial adenocarcinomas in the BDII rat model as revealed by chromosome banding and comparative genome hybridization. Cancer Genet Cytogenet 159:123–128.
Walentinsson A, Helou K, Wallenius V, et al. (2001) Independent amplification of two gene clusters on chromosome 4 in rat endometrial cancer: identification and molecular characterization. Cancer Res 61:8263–8273.
Adamovic T, Trossö F, Roshani L, et al. (2005) Oncogene amplification in the proximal part of chromosome 6 in rat endometrial adenocarcinomas as revealed by combined BAC/PAC FISH analysis, chromosome painting, zoo-FISH and allelotyping analysis. Genes Chromosom Cancer 44:139–153.
Andersson L, Archibald A, Ashburner M, et al. (1996) Comparative genome organization of vertebrates. The First International Workshop on Comparative Genome Organization. Mamm Genome 7:717–734.
Lim J, Mansukhani M, Weinstein I (2005) Proc Natl Acad Sci USA 14:5156–5161.
Costello JF, Plass C, Arap W, et al. (1997) Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res 57:1250–1254.
Hirai Y, Utsugi K, Takeshima N, et al. (2004) Putative gene loci associated with carcinogenesis and metastasis of endocervial adenocarcinomas of uterus determined by conventional and array-based CGH. Am J Obstet Gynecol 191:1173–1182.
Wullich B, Muller HW, Fischer U, et al. (1993) Amplified met gene linked to double minutes in human glioblastoma. Eur J Cancer 29A:1991–1995.
Wullich B, Sattler HP, Fischer U, et al. (1994) Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET. Anticancer Res 14:577–579.
Nakajima M, Sawada H, Yamada Y, et al. (1999) The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 85:1894–1902.
Karlsson A, Helou K, Walentinsson A, et al. (2001) Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas. Gene Chromosome Cancer 31:345–356.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer
About this chapter
Cite this chapter
Samuelson, E., Nordlander, C., Levan, G., Behboudi, A. (2008). Amplification Studies of MET and Cdk6 in a Rat Endometrial Tumor Model and Their Correlation to Human Type I Endometrial Carcinoma Tumors. In: Li, J.J., Li, S.A., Mohla, S., Rochefort, H., Maudelonde, T. (eds) Hormonal Carcinogenesis V. Advances in Experimental Medicine and Biology, vol 617. Springer, New York, NY. https://doi.org/10.1007/978-0-387-69080-3_51
Download citation
DOI: https://doi.org/10.1007/978-0-387-69080-3_51
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-69078-0
Online ISBN: 978-0-387-69080-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)